{"product_id":"9783319322308","title":"Algae-Based Biopharmaceuticals","description":"\u003ch1\u003eAlgae-Based Biopharmaceuticals\u003c\/h1\u003e \u003ch2\u003eRosales-Mendoza, Sergio\u003c\/h2\u003e \u003cp\u003e\u003c\/p\u003e\u003cp\u003eThis book constitutes a key reference on the use of algae in the biopharmaceuticals  production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.\u003c\/p\u003e\u003cp\u003eThis book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for  the production of recombinant proteins with medical applications. Among the  features that make them attractive candidates are: low cost, fast growth, wide  biosynthetic capacity, and absence of human pathogens; which constitute  substantial advantages with respect to bacterial and mammalian systems. \u003c\/p\u003e\n\u003cp\u003eFirst,  the features of algae as convenient hosts for the production of BFs are analyzed  in terms of production costs, biosynthetic capacity, and safety (Chapter 1).  Second, the genetic engineering tools for algae-species are described. Nuclear  and chloroplast-based expression approaches are analyzed and compared in terms  of biosynthetic advantages, gene expression complexity, and DNA transfer  approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of  the art on producing distinct types of BFs in algae species is presented.  Although this book is mainly focused on BFs, considering that the production of  compounds with health-promoting properties are achieved using  genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In  the ninth chapter, the developments reported thus far are placed in perspective  and challenges for the field are discussed. Critical future prospects comprise  the following: optimizing large-scale production in bioreactors, implementing  glycoengineering approaches, optimizing nuclear expression, exploring new  approaches for oral delivery, and implementing regulatory frameworks to  accomplish technology transferand regulatory approval of algae-made  BFs.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2016-05-31\u003c\/p\u003e \u003cp\u003eFormat: Hardcover\u003c\/p\u003e \u003cp\u003eISBN-13: 9783319322308\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-3-319-32232-2\u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 166\u003c\/p\u003e ","brand":"Springer International Publishing","offers":[{"title":"Default Title","offer_id":44395503452300,"sku":"9783319322308","price":98.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783319322308.jpg?v=1772933875","url":"https:\/\/lateknightbooks.com\/products\/9783319322308","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}